TABLE 2.
Cirrhosis | HCC | ||||||
---|---|---|---|---|---|---|---|
Patients (n) | Incident Cases (n) | Follow-up (PY) | Cirrhosis Incidences per 1,000 PY (95% CI) | Incident Cases (n) | Follow-up (PY) | HCC Incidences per 1,000 PY (95% CI) | |
Steatosis + normal ALT | 3,522 | 31 | 25,336 | 1.22 (0.83, 1.74) | 5 | 25,441 | 0.20 (0.06, 0.46) |
Steatosis + elevated ALT | 15,419 | 435 | 112,950 | 3.85 (3.50, 4.23) | 42 | 114,749 | 0.37 (0.26, 0.49) |
No steatosis + normal ALT | 9,267 | 61 | 62,955 | 0.97 (0.74, 1.24) | 4 | 63,232 | 0.06 (0.02, 0.16) |